Cargando…

Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary

Tumor immune escape is associated with both, the expression of immune checkpoint molecules on peripheral immune cells and soluble forms of the human leukocyte antigen-G (HLA-G) in the blood, which are consequently discussed as clinical biomarker for disease status and outcome of cancer patients. HLA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwich, Esther, Hò, Gia-Gia T., LeMaoult, Joel, Bade-Döding, Christina, Carosella, Edgardo D., Horn, Peter A., Rebmann, Vera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472666/ https://www.ncbi.nlm.nih.gov/pubmed/32973812 http://dx.doi.org/10.3389/fimmu.2020.02046

Ejemplares similares

Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC
por: Wu, Ching-Lien, et al.
Publicado: (2021)

Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients
por: Rohn, Hana, et al.
Publicado: (2023)

HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
por: Lin, Aifen, et al.
Publicado: (2021)

The Dual Role of HLA-G in Cancer
por: Rouas-Freiss, Nathalie, et al.
Publicado: (2014)

The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma
por: García, Marcela, et al.
Publicado: (2020)

Effect of HLA-G5 Immune Checkpoint Molecule on the Expression of ILT-2, CD27, and CD38 in Splenic B cells
por: Rohn, Hana, et al.
Publicado: (2022)

Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients
por: Hoffmann, Oliver, et al.
Publicado: (2023)

Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer
por: Chen, Qiong-Yuan, et al.
Publicado: (2021)

Vesicular-Bound HLA-G as a Predictive Marker for Disease Progression in Epithelial Ovarian Cancer
por: Schwich, Esther, et al.
Publicado: (2019)

Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG’s receptor ILT2 on peripheral CD8(+) T cells
por: Desgrandchamps, Francois, et al.
Publicado: (2018)

Editorial: The Biological and Clinical Aspects of HLA-G
por: LeMaoult, Joel, et al.
Publicado: (2021)

Expression of immunoglobulin-like transcript (ILT)2 and ILT3 in human gastric cancer and its clinical significance
por: ZHANG, YI, et al.
Publicado: (2012)

Editorial: The Biological and Clinical Aspects of HLA-G, Volume II
por: LeMaoult, Joel, et al.
Publicado: (2022)

Tolerogenic Function of Dimeric Forms of HLA-G Recombinant Proteins: A Comparative Study In Vivo
por: Favier, Benoit, et al.
Publicado: (2011)

The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology
por: Rebmann, Vera, et al.
Publicado: (2016)

Recombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small Bowel Transplantation
por: von Websky, Martin W., et al.
Publicado: (2016)

Novel landscape of HLA‐G isoforms expressed in clear cell renal cell carcinoma patients
por: Tronik‐Le Roux, Diana, et al.
Publicado: (2017)

NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain
por: Hò, Gia-Gia T., et al.
Publicado: (2020)

Polymorphic Sites at the 3’ Untranslated Region of the HLA-G Gene Are Associated with Differential hla-g Soluble Levels in the Brazilian and French Population
por: Martelli-Palomino, Gustavo, et al.
Publicado: (2013)

Human Keratinocytes Inhibit CD4(+) T-Cell Proliferation through TGFB1 Secretion and Surface Expression of HLA-G1 and PD-L1 Immune Checkpoints
por: Mestrallet, Guillaume, et al.
Publicado: (2021)

Skin Immunity and Tolerance: Focus on Epidermal Keratinocytes Expressing HLA-G
por: Mestrallet, Guillaume, et al.
Publicado: (2021)

The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection
por: Brown, Damien P, et al.
Publicado: (2009)

Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G
por: Lombard, Catherine A., et al.
Publicado: (2019)

Non-classical transcriptional regulation of HLA-G: an update
por: Moreau, Philippe, et al.
Publicado: (2010)

Non-classical transcriptional regulation of HLA-G: an update
por: Moreau, Philippe, et al.
Publicado: (2009)

HLA-F*01:01 presents peptides with N-terminal flexibility and a preferred length of 16 residues
por: Hò, Gia-Gia T., et al.
Publicado: (2019)

HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
por: Li, Peilong, et al.
Publicado: (2021)

Haplotypes of the HLA-G 3’ Untranslated Region Respond to Endogenous Factors of HLA-G+ and HLA-G- Cell Lines Differentially
por: Poras, Isabelle, et al.
Publicado: (2017)

HLA-G peptide preferences change in transformed cells: impact on the binding motif
por: Celik, Alexander A., et al.
Publicado: (2018)

HLA-G 3′ untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer
por: Schwich, Esther, et al.
Publicado: (2019)

Air sampling for detection of infectious laryngotracheitis (ILT) in commercial poultry flocks
por: Brown, Lauren, et al.
Publicado: (2020)

Crystal structure of LIR-2 (ILT4) at 1.8 Å: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18
por: Willcox, Benjamin E, et al.
Publicado: (2002)

The microstructure in the placenta is influenced by the functional diversity of HLA-G allelic variants
por: Stieglitz, F., et al.
Publicado: (2019)

Recipient HLA-G +3142 CC Genotype and Concentrations of Soluble HLA-G Impact on Occurrence of CMV Infection after Living-Donor Kidney Transplantation
por: Guberina, Hana, et al.
Publicado: (2017)

Downregulation of Immunoglobulin-Like Transcript-4 (ILT4) in Patients with Psoriatic Arthritis
por: Bergamini, Alberto, et al.
Publicado: (2014)

Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity
por: Gao, Aiqin, et al.
Publicado: (2021)

Human Semaphorin-4A drives Th2 responses by binding to receptor ILT-4
por: Lu, Ning, et al.
Publicado: (2018)

HLA-G as a Tolerogenic Molecule in Transplantation and Pregnancy
por: Rebmann, Vera, et al.
Publicado: (2014)

Trogocytic intercellular membrane exchanges among hematological tumors
por: LeMaoult, Joel, et al.
Publicado: (2015)

Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment
por: Wu, Danli, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hi6vu16cil4bini6eba50h36iq